XML 86 R77.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivative Instruments and Hedging Activities - Impact and Location of Derivative Instruments for Derivatives Designated as Cash Flow Hedging and the Related Components Excluded From Effectiveness Testing (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 29, 2022
Jul. 30, 2021
Jul. 29, 2022
Jul. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales $ 1,160,550 $ 976,836 $ 3,342,678 $ 2,998,929
Cost of Sales (760,644) (645,719) (2,236,927) (1,949,823)
Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings 1,840 (3,082) 1,595 (9,265)
Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales 1,160,550 976,836 3,342,678 2,998,929
Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Cost of Sales (760,644) (645,719) (2,236,927) (1,949,823)
Forward currency contracts | Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings 1,640 (3,113) 1,431 (9,325)
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value 646 322 (930) 784
Forward currency contracts | Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings 200 31 164 60
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ 627 $ 70 $ 1,180 $ 366